Back to Journals » Vascular Health and Risk Management » Volume 10 » default

Vascular Health and Risk Management

ISSN: 1178-2048


Archive: Volume 10, 2014

Effects of exercise timing on sleep architecture and nocturnal blood pressure in prehypertensives

Fairbrother K, Cartner B, Alley JR, Curry CD, Dickinson DL, Morris DM, Collier SR

Vascular Health and Risk Management 2014, 10:691-698

Published Date: 12 December 2014

Prevalence of risk factors at presentation and early mortality in patients aged 80 years or older with ST-segment elevation myocardial infarction

Claussen PA, Abdelnoor M, Kvakkestad KM, Eritsland J, Halvorsen S

Vascular Health and Risk Management 2014, 10:683-689

Published Date: 9 December 2014

Complications of the endovascular management of acute ischemic stroke

Gill HL, Siracuse JJ, Parrack IK, Huang ZS, Meltzer AJ

Vascular Health and Risk Management 2014, 10:675-681

Published Date: 28 November 2014

Macitentan for the treatment of pulmonary arterial hypertension

Kholdani CA, Fares WH, Trow TK

Vascular Health and Risk Management 2014, 10:665-673

Published Date: 25 November 2014

Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review

Gómez-Outes A, Suárez-Gea ML, Lecumberri R, Terleira-Fernández AI, Vargas-Castrillón E

Vascular Health and Risk Management 2014, 10:627-639

Published Date: 7 November 2014

Congenital anomaly of the inferior vena cava and factor V Leiden mutation predisposing to deep vein thrombosis

Lamparello BM, Erickson CR, Kulthia A, Virparia V, Thet Z

Vascular Health and Risk Management 2014, 10:609-613

Published Date: 4 November 2014

Optimal management of infrainguinal arterial occlusive disease

Pennywell DJ, Tan TW, Zhang WW

Vascular Health and Risk Management 2014, 10:599-608

Published Date: 24 October 2014

Consumption of water containing over 3.5 mg of dissolved hydrogen could improve vascular endothelial function

Sakai T, Sato B, Hara K, Hara Y, Naritomi Y, Koyanagi S, Hara H, Nagao T, Ishibashi T

Vascular Health and Risk Management 2014, 10:591-597

Published Date: 17 October 2014

Economic and outcomes consequences of TachoSil®: a systematic review

Colombo GL, Bettoni D, Di Matteo S, Grumi C, Molon C, Spinelli D, Mauro G, Tarozzo A, Bruno GM

Vascular Health and Risk Management 2014, 10:569-576

Published Date: 10 September 2014

Sex differences in long-term outcomes of coronary patients treated with drug-eluting stents at a tertiary medical center

Shammas NW, Shammas GA, Jerin M, Sharis P

Vascular Health and Risk Management 2014, 10:563-568

Published Date: 9 September 2014

Adding multiple risk factors improves Framingham coronary heart disease risk scores

Hu G, Root M, Duncan AW

Vascular Health and Risk Management 2014, 10:557-562

Published Date: 5 September 2014

A three-dimensional electronic report of a venous echo color Doppler of the lower limbs: MEVeC®

Galeandro AI, Scicchitano P, Zito A, Galeandro C, Gesualdo M, Ciciarello F, Cecere A, Marzullo A, Contursi V, Annicchiarico A, Ciccone MM

Vascular Health and Risk Management 2014, 10:549-555

Published Date: 1 September 2014

Perindopril for improving cardiovascular events

DiNicolantonio JJ, O’Keefe JH

Vascular Health and Risk Management 2014, 10:539-548

Published Date: 30 August 2014

Coronary microvascular endothelial dysfunction is an independent predictor of development of osteoporosis in postmenopausal women

Prasad M, Reriani M, Khosla S, Gössl M, Lennon R, Gulati R, Prasad A, Lerman LO, Lerman A

Vascular Health and Risk Management 2014, 10:533-538

Published Date: 26 August 2014

Thoracoabdominal aortic aneurysm repair: current endovascular perspectives

Orr N, Minion D, Bobadilla JL

Vascular Health and Risk Management 2014, 10:493-505

Published Date: 19 August 2014

Insulin degludec/insulin aspart combination for the treatment of type 1 and type 2 diabetes

Dardano A, Bianchi C, Del Prato S, Miccoli R

Vascular Health and Risk Management 2014, 10:465-475

Published Date: 5 August 2014

XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation

Camm AJ, Amarenco P, Haas S, Hess S, Kirchhof P, Eickels MV, Turpie AGG

Vascular Health and Risk Management 2014, 10:425-434

Published Date: 17 July 2014

Lower extremity amputation in peripheral artery disease: improving patient outcomes

Swaminathan A, Vemulapalli S, Patel MR, Jones WS

Vascular Health and Risk Management 2014, 10:417-424

Published Date: 16 July 2014

Carotid revascularization: risks and benefits

O'Brien M, Chandra A

Vascular Health and Risk Management 2014, 10:403-416

Published Date: 7 July 2014

Epidemiology of stroke in a rural community in Southeastern Nigeria

Enwereji KO, Nwosu MC, Ogunniyi A, Nwani PO, Asomugha AL, Enwereji EE

Vascular Health and Risk Management 2014, 10:375-388

Published Date: 24 June 2014

Defining risks and predicting adverse events after lower extremity bypass for critical limb ischemia

Siracuse JJ, Huang ZS, Gill HL, Parrack I, Schneider DB, Connolly PH, Meltzer AJ

Vascular Health and Risk Management 2014, 10:367-374

Published Date: 23 June 2014

Update on ranolazine in the management of angina

Codolosa JN, Acharjee S, Figueredo VM

Vascular Health and Risk Management 2014, 10:353-362

Published Date: 24 June 2014

How are patients with type 2 diabetes and renal disease monitored and managed? Insights from the observational OREDIA study

Penfornis A, Blicklé JF, Fiquet B, Quéré S, Dejager S

Vascular Health and Risk Management 2014, 10:341-352

Published Date: 13 June 2014

Serum lipid profile and its association with hypertension in Bangladesh

Choudhury KN, Mainuddin AKM, Wahiduzzaman M, Islam SMS

Vascular Health and Risk Management 2014, 10:327-332

Published Date: 30 June 2014

Blood and urine levels of heavy metal pollutants in female and male patients with coronary artery disease

Sponder M, Fritzer-Szekeres M, Marculescu R, Mittlböck M, Uhl M, Köhler-Vallant B, Strametz-Juranek J

Vascular Health and Risk Management 2014, 10:311-317

Published Date: 13 May 2014

Validation of the custo screen 400 ambulatory blood pressure-monitoring device according to the European Society of Hypertension International Protocol revision 2010

Bramlage P, Deutsch C, Krüger R, Wolf A, Müller P, Zwingers T, Beime B, Mengden T

Vascular Health and Risk Management 2014, 10:303-309

Published Date: 13 May 2014

Influence of serological factors and BMI on the blood pressure/hematocrit association in healthy young men and women

Salazar Vázquez BY, Salazar Vázquez MA, Chávez-Negrete A, Escobedo G, Cabrales P, Subramaniam S, Intaglietta M, Pérez-Tamayo R

Vascular Health and Risk Management 2014, 10:271-277

Published Date: 6 May 2014

Serum uric acid and target organ damage in essential hypertension

Ofori SN, Odia OJ

Vascular Health and Risk Management 2014, 10:253-261

Published Date: 2 May 2014

The 24-hour pulse wave velocity, aortic augmentation index, and central blood pressure in normotensive volunteers

Kuznetsova TY, Korneva VA, Bryantseva EN, Barkan VS, Orlov AV, Posokhov IN, Rogoza AN

Vascular Health and Risk Management 2014, 10:247-251

Published Date: 28 April 2014

Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US

Marrett E, Zhao C, Zhang NJ, Zhang Q, Ramey DR, Tomassini JE, Tershakovec AM, Neff DR

Vascular Health and Risk Management 2014, 10:237-246

Published Date: 25 April 2014

Factors influencing dyslipidemia in statin-treated patients in Lebanon and Jordan: results of the Dyslipidemia International Study

Azar ST, Hantash HA, Jambart S, El-Zaheri MM, Rachoin R, Chalfoun A, Lahoud L, Okkeh O, Bramlage P, Brudi P, Ambegaonkar BM

Vascular Health and Risk Management 2014, 10:225-235

Published Date: 7 May 2014

Telemonitoring: use in the management of hypertension

Sivakumaran D, Earle KA

Vascular Health and Risk Management 2014, 10:217-224

Published Date: 10 April 2014

Current guidelines for high-density lipoprotein cholesterol in therapy and future directions

Subedi BH, Joshi PH, Jones SR, Martin SS, Blaha MJ, Michos ED

Vascular Health and Risk Management 2014, 10:205-216

Published Date: 8 April 2014

Stroke and diabetic ketoacidosis – some diagnostic and therapeutic considerations

Jovanovic A, Stolic RV, Rasic DV, Markovic-Jovanovic SR, Peric VM

Vascular Health and Risk Management 2014, 10:201-204

Published Date: 8 April 2014

Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty

Levitan B, Yuan Z, Turpie AGG, Friedman RJ, Homering M, Berlin JA, Berkowitz SD, Weinstein RB, DiBattiste PM

Vascular Health and Risk Management 2014, 10:157-167

Published Date: 26 March 2014

The "Pulse Time Index of Norm" highly correlates with the left ventricular mass index in patients with arterial hypertension

Posokhov IN, Kulikova NN, Starchenkova IV, Grigoricheva EA, Evdokimov VV, Orlov AV, Rogoza AN

Vascular Health and Risk Management 2014, 10:139-144

Published Date: 19 March 2014

Challenges associated with peripheral arterial disease in women

Barochiner J, Aparicio LS, Waisman GD

Vascular Health and Risk Management 2014, 10:115-128

Published Date: 10 March 2014

Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke

Chapman SN, Mehndiratta P, Johansen MC, McMurry TL, Johnston KC, Southerland AM

Vascular Health and Risk Management 2014, 10:75-87

Published Date: 24 February 2014

Increased prevalence of coronary artery disease risk markers in patients with chronic hepatitis C – a cross-sectional study

Roed T, Kristoffersen US, Knudsen A, Wiinberg N, Lebech AM, Almdal T, Thomsen RW, Kjær A, Weis N

Vascular Health and Risk Management 2014, 10:55-62

Published Date: 21 January 2014

Is higher body temperature beneficial in ischemic stroke patients with normal admission CT angiography of the cerebral arteries?

Kvistad CE, Khanevski A, Nacu A, Thomassen L, Waje-Andreassen U, Naess H

Vascular Health and Risk Management 2014, 10:49-54

Published Date: 21 January 2014

Dabigatran and myocardial infarction: a foggy scenario

Pontillo D, Patruno N

Vascular Health and Risk Management 2014, 10:45-48

Published Date: 20 January 2014